Trades on 2 secondary markets

Cartography Biosciences

Cartography Biosciences is a South San Francisco biotechnology company developing precision cancer immunotherapies designed around tumor-selective antigens. Using single-cell genomics, proteomics, and novel binder-discovery methods, the company profiles antigen expression across thousands of patient

minimal 14.3 / 100 0 APIs View provider profile →
CompanyBiotechnologyCancerImmunotherapyOncologyGenomics

Cartography Biosciences is an API provider whose private shares are listed on 2 secondary markets: EquityZen, Nasdaq Private Market.

Where It Trades

EZ EquityZen View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.